AI drug discovery
Sensorium Therapeutics Raises $25M Series A to Advance Nature-Inspired Brain Health Treatments
September 6, 2025
bySensorium Therapeutics, a clinical-stage biotech startup based in Boston founded by Jacob Hooker, has raised $25 million in Series A...
Read MoreTahoe Therapeutics Raises $30M to Build Billion-Cell Dataset for AI Drug Discovery
August 15, 2025
byA New Foundation for Virtual Cell Models Tahoe Therapeutics, the South San Francisco startup building virtual models of human cells,...
Read MoreOne Biosciences Closes $17.38M Series A to Advance AI-Powered Drug Discovery
July 27, 2025
byOne Biosciences, a trailblazing biotech company at the intersection of single-cell analysis and artificial intelligence, has successfully raised $17.38 million...
Read MoreSynfini Raises $8.9 Million to Transform AI-Driven Drug Discovery
July 11, 2025
bySynfini Inc., an emerging leader in AI-driven drug discovery, has announced an $8.9 million funding round to accelerate its mission...
Read More


